132 related articles for article (PubMed ID: 17159357)
1. Drug discovery and delivery in the 21st century.
Triggle DJ
Med Princ Pract; 2007; 16(1):1-14. PubMed ID: 17159357
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Multidimensional atomic force microscopy for drug discovery: a versatile tool for defining targets, designing therapeutics and monitoring their efficacy.
Lal R; Arnsdorf MF
Life Sci; 2010 Apr; 86(15-16):545-62. PubMed ID: 20359578
[TBL] [Abstract][Full Text] [Related]
4. Commercial potential of RNAi.
Jain KK
Mol Biosyst; 2006 Nov; 2(11):523-6. PubMed ID: 17216033
[TBL] [Abstract][Full Text] [Related]
5. Genomics and systems biology in malaria drug discovery.
Dharia NV; Chatterjee A; Winzeler EA
Curr Opin Investig Drugs; 2010 Feb; 11(2):131-8. PubMed ID: 20112162
[TBL] [Abstract][Full Text] [Related]
6. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.
Foekens JA; Wang Y; Martens JW; Berns EM; Klijn JG
Drug Discov Today; 2008 Jun; 13(11-12):481-7. PubMed ID: 18549973
[TBL] [Abstract][Full Text] [Related]
7. [Biomarkers: "Found in translation"].
Lockhart BP; Walther B
Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
[TBL] [Abstract][Full Text] [Related]
8. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
9. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
10. Druggable targets and targeted drugs: enhancing the development of new therapeutics.
Billingsley ML
Pharmacology; 2008; 82(4):239-44. PubMed ID: 18802381
[TBL] [Abstract][Full Text] [Related]
11. Progress towards personalized medicine.
Bates S
Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
[TBL] [Abstract][Full Text] [Related]
12. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive structural, functional, and molecular imaging in drug development.
Rudin M
Curr Opin Chem Biol; 2009 Jun; 13(3):360-71. PubMed ID: 19447067
[TBL] [Abstract][Full Text] [Related]
14. Genomics and proteomics tools for compound mode-of-action studies in drug discovery.
Kley N; Ivanov I; Meier-Ewert S
Pharmacogenomics; 2004 Jun; 5(4):395-404. PubMed ID: 15165175
[TBL] [Abstract][Full Text] [Related]
15. The chemical hunt for the identification of drugable targets.
Meisner NC; Hintersteiner M; Uhl V; Weidemann T; Schmied M; Gstach H; Auer M
Curr Opin Chem Biol; 2004 Aug; 8(4):424-31. PubMed ID: 15338571
[TBL] [Abstract][Full Text] [Related]
16. When will the genomics investment pay off for antibacterial discovery?
Mills SD
Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
[TBL] [Abstract][Full Text] [Related]
17. [Pathology and clinical medicine in the 21st Century].
Denk H
Verh Dtsch Ges Pathol; 2001; 85():80-6. PubMed ID: 11894418
[TBL] [Abstract][Full Text] [Related]
18. Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century.
Schnackenberg LK
Expert Rev Mol Diagn; 2007 May; 7(3):247-59. PubMed ID: 17489732
[TBL] [Abstract][Full Text] [Related]
19. Computational chemistry approaches to drug discovery in signal transduction.
Fischer PM
Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
[TBL] [Abstract][Full Text] [Related]
20. Integrating genomics across drug discovery and development.
Debouck C
Toxicol Lett; 2009 Apr; 186(1):9-12. PubMed ID: 18930125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
